About TriAgenics
TriAgenics is a company based in Redmond (United States) founded in 2016.. TriAgenics has raised $5.5 million across 2 funding rounds. The company has 2 employees as of December 31, 2023. TriAgenics offers products and services including Zero3™ TBA. TriAgenics operates in a competitive market with competitors including Doxa, Reminova, GO SMiLE, DentoFit and CERAMIR, among others.
- Headquarter Redmond, United States
- Employees 2 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Triagenics, Inc
-
Annual Revenue
-
Net Profit
$-1.44 M-1as on Dec 31, 2023
-
EBITDA
-
Total Equity Funding
$5.5 M (USD)
in 2 rounds
-
Latest Funding Round
$500 K (USD), Series A
Apr 11, 2025
-
Investors
-
Employee Count
2
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TriAgenics
TriAgenics offers a comprehensive portfolio of products and services, including Zero3™ TBA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Procedure to prevent wisdom teeth by warming tooth buds in animals.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of TriAgenics
TriAgenics has successfully raised a total of $5.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $500,000
-
First Round
First Round
(17 Jan 2025)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - TriAgenics | Valuation |
investors |
|
| Jan, 2025 | Amount | Series A - TriAgenics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by TriAgenics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TriAgenics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Triagenics Comparisons
Competitors of TriAgenics
TriAgenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Doxa, Reminova, GO SMiLE, DentoFit and CERAMIR, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Doxa is engaged in developing and selling real estate projects.
|
|
| domain | founded_year | HQ Location |
Remineralization technology for dental caries and tooth whitening
|
|
| domain | founded_year | HQ Location |
Teeth whitening solutions
|
|
| domain | founded_year | HQ Location |
Composite resin technology is developed for dental applications.
|
|
| domain | founded_year | HQ Location |
Dental consumables and instruments are developed and manufactured by CERAMIR.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TriAgenics
When was TriAgenics founded?
TriAgenics was founded in 2016 and raised its 1st funding round 9 years after it was founded.
Where is TriAgenics located?
TriAgenics is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Who is the current CEO of TriAgenics?
Leigh Colby is the current CEO of TriAgenics.
Is TriAgenics a funded company?
TriAgenics is a funded company, having raised a total of $5.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jan 17, 2025.
How many employees does TriAgenics have?
As of Dec 31, 2023, the latest employee count at TriAgenics is 2.
What does TriAgenics do?
TriAgenics was founded in 2016 and is based in Redmond, United States. Operations focus on the development of a minimally invasive procedure targeted at tooth buds to halt wisdom teeth formation. Safety and efficacy have been evaluated through animal studies, with the treatment currently unapproved for human application. The company operates in the dental biotechnology sector.
Who are the top competitors of TriAgenics?
What products or services does TriAgenics offer?
TriAgenics offers Zero3™ TBA.